Once laboratory results are received, eligible subjects will be scheduled for Study Visit 7. At Visit 7, subjects must continue to meet ADHD-RS-IV eligibility criteria. Subjects who can continue in the trial will begin open-label treatment, study drug will be dispensed, and participants will be scheduled for their next visit. See Section 6.1.1 for a detailed list of procedures.